April 23, 2024

BeLab21/22 BRIDGE

BeLab21/22 BRIDGE

Mediated and supported by BioRN, Evotec established in 2021 the beLAB2122 BRIDGE. With 20M Euro Fund for preclinical development of academic drug discovery projects, beLAB2122 is a new public-private partnership between the leading academic institutions of the Rhine-Main-Neckar region, Evotec and Bristol Myers Squibb to identify, fund and execute novel disease modifying therapeutic projects with the goal to develop these to new spinout companies.

tester

Our latest News

discover more
New Member: Welcome in our cluster to iQMedix GmbH

New Member: Welcome in our cluster to iQMedix GmbH

iQMedix aims to improve the lives of cancer patients by providing personalized treatments based on molecular analysis. Using liquid biopsies to determine gene expression profiles from circulating tumor cells, iQMedix enables doctors to tailor therapies to each patient’s unique cancer. Their approach offers precise insights to determine effective treatments. Their vision is to make cancer […]

New Member: Welcome in our cluster to !LEVA Sciences GmbH

New Member: Welcome in our cluster to !LEVA Sciences GmbH

!LEVA specializes in guiding pharmaceutical companies through the complexities of development, from company foundation to early clinical studies. Over the past 25 years, the !LEVA management team has co-founded and successfully managed nearly a dozen companies, mainly in the pharmaceutical sector, while supporting numerous biotech companies in corporate and product development. !LEVA Sciences was founded […]

New Member: Welcome in our cluster to OMNI Life Science GmbH & Co. KG

New Member: Welcome in our cluster to OMNI Life Science GmbH & Co. KG

OLS – OMNI Life Science accelerates cell research with smart, reliable, and user-friendly technologies for life sciences and biotechnology. Their products are used in public, private, pharmaceutical, and biotech labs. The portfolio includes instruments, media, reagents, consumables, and services for Cell Counting, Culture, Imaging, Flow Cytometry, and Analysis. OLS supports researchers throughout the entire process, […]

GET IN TOUCH

Stay Updated with bioRN’s Newsletter

Sign up for our newsletter to discover more!